Last reviewed · How we verify
A Double-Blind, Parallel-Group Study of the Safety, Tolerability and Immunogenicity of a Range of Doses and Dosing Schedules of Recombinant (rPA Based) Anthrax Vaccine in Healthy Subjects
This is a dose ranging study comparing different vaccine schedules of rPA vaccine for anthrax. Safety and the capability to induce an immune response will be evaluated.
Details
| Lead sponsor | PharmAthene UK Limited |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 415 |
| Start date | 2005-03 |
| Completion | 2007-02 |
Conditions
- Prevention of Bacillus Anthracis (Anthrax) Infection
Interventions
- rPA vaccine containing alhydrogel
Primary outcomes
- Safety of rPA vaccine
Countries
United Kingdom